Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial To Assess The Feasibility And Efficacy Of Subcutaneous Immunoglobulin In Patients With Myasthenia Gravis Exacerbation

NCT02774239 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT02774239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02774239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial To Assess The Feasibility And Efficacy Of Subcutaneous Immunoglobulin In Patients With Myasthenia Gravis Exacerbation
Lead sponsor
University of Alberta
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2014
Completion date
October 21, 2022
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

myasthenia gravis